Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30
Published August 15, 2012 · Recall initiated: May 18, 2012
Summary
FDA records drug Class II recall D-1442-2012, published August 15, 2012 and initiated May 18, 2012. Recalling firm: Teva Pharmaceuticals USA, Inc.; Status: Terminated; Reported quantity: 6,647 cartons; Lot: Lot number X05011, Exp 08/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.
What to do
Voluntary: Firm initiated · Letter
Get an email if COPAXONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- COPAXONE
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Distributor
- Nationwide
- Lot
- Lot number X05011, Exp 08/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACopaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-useNovember 27, 2013
- FDACopaxone (glatiramer acetate injection), 20 mg/1 mL, packaged in 30 single use PRE-FILLED syringes and 33April 24, 2013
- FDAMeloxicam Tablets, USP, 15 mg, Rx Only, 100 Tablets per Bottle, Manufactured by: Strides Acrolab Ltd.,August 15, 2012
- FDAHYDROmorphone HCl Injection, USP, 1 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packagedAugust 15, 2012
- FDARF Cannula, 100 mm,Curved 10 MM, 20 G, REF 0406-630-125 RX only, Disposable ( 10/pk) Product Usage: TheAugust 8, 2012
- FDARF Cannula, 100 mm,Curved 5 MM, 20 G, REF 0406-630-115 RX only, Disposable ( 10/pk) Product Usage: The StrykerAugust 8, 2012
Questions about this recall
Was Copaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30 recalled?
Yes. FDA published recall D-1442-2012 on August 15, 2012. Reported hazard: Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: COPAXONE.